In this sense, in a study by Wang et al. [160], a novel MSN loaded with both multidrug resistance protein 1 (MDR1) siRNA and DOX was evaluated in vitro and in vivo to directly kill tumor cells without the effect of multidrug resistance. The gene discussed is ABCB1; the disease is neoplasm.